2026 NPPES data Vascular Neurology Physician NPI 1902480874 MD
Verify on CMS →

SHREEJA KADAKIA, MD

Vascular Neurology Physician in HERSHEY, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
131
Medicare Part D claims · 38 beneficiaries · Vascular Neurology Physician avg: 378
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

SHREEJA KADAKIA, MD filed 131 Medicare Part D claims in 2023 as a Vascular Neurology Physician in HERSHEY, Pennsylvania, prescribing 91% generic.

131
Part D claims, 2023
91%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

SHREEJA KADAKIA, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

131 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

SHREEJA KADAKIA, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about SHREEJA KADAKIA, MD?

Quality data not reported

NPI registry status

Active

Issued 05/07/2021

NPI 1902480874

Primary specialty

Vascular Neurology Physician

Niche

555 US NPIs in this specialty

Medicare Part D claims

131 65% vs specialty avg

2023 prescription claims

Specialty avg: 378

Specialty distribution in Pennsylvania

How Vascular Neurology Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Vascular Neurology Physician share within Pennsylvania

1. Vascular Neurology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Vascular Neurology Physician share within Pennsylvania

Specialty board-certification context

Estimated specialty board-certified rate — Vascular Neurology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Vascular Neurology Physician ABMS/AOA estimate

Est. board-certified rate (Vascular Neurology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Vascular Neurology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SHREEJA KADAKIA, MD appears in the CMS NPPES registry as a Vascular Neurology Physician provider holding MD credentials at 500 UNIVERSITY DR, HERSHEY, PA, 17033, with a listed phone of (717) 531-0003. NPI 1902480874 was issued on 05/07/2021. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KADAKIA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 131 prescription claims written by this provider, covering 38 Medicare beneficiaries and totaling roughly $12K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Vascular Neurology Physician is a narrow specialty nationwide, with 555 enrolled providers across 47 states and an average of 378 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

500 UNIVERSITY DR
HERSHEY, PA 17033

Provider Details

NPI 1902480874
Specialty Vascular Neurology Physician
Credentials MD
Gender Female
NPI Issued 05/07/2021

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to SHREEJA KADAKIA, MD. To verify SHREEJA KADAKIA, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

SHREEJA KADAKIA, MD — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 131 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

131
Total Claims
$12K
Total Drug Cost
38
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
201
Total Day Supply
5,763
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$9K
Generic Drug Cost
$3K

Patient Demographics

Average Patient Age
71.2 years
Avg HCC Risk Score
1.74
Gender Split
68% female / 32% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What SHREEJA KADAKIA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Clopidogrel
Clopidogrel Bisulfate
19
Carbidopa-Levodopa
Carbidopa/Levodopa
18
Duloxetine Hcl
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Vascular Neurology Physician Overview

How SHREEJA KADAKIA, MD fits within the Vascular Neurology Physician landscape nationally.

555
Vascular Neurology Physician Providers in US
47
States with Vascular Neurology Physician
378
Avg Claims per Provider

SHREEJA KADAKIA, MD's 131 claims are below the specialty average of 378.

Nearby Vascular Neurology Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as KADAKIA.

Compare Vascular Neurology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SHREEJA KADAKIA, MD's specialty?
SHREEJA KADAKIA, MD specializes in Vascular Neurology Physician and practices in HERSHEY, Pennsylvania. Credentials: MD.
How much does SHREEJA KADAKIA, MD prescribe under Medicare Part D?
In 2023, SHREEJA KADAKIA, MD wrote 131 Medicare Part D claims totaling $12K in drug costs for 38 beneficiaries.
Where is SHREEJA KADAKIA, MD located?
SHREEJA KADAKIA, MD is located at 500 UNIVERSITY DR, HERSHEY, PA, 17033. Phone: (717) 531-0003.
What is SHREEJA KADAKIA, MD's NPI number?
SHREEJA KADAKIA, MD's National Provider Identifier (NPI) is 1902480874, issued on 05/07/2021.
Does SHREEJA KADAKIA, MD prescribe more brand-name or generic drugs?
SHREEJA KADAKIA, MD's prescribing is 9% brand-name and 91% generic drugs by claim count, with $9K in brand drug costs.
How many Vascular Neurology Physician providers are there in the US?
There are 555 Vascular Neurology Physician providers across 47 states in the US. The average Vascular Neurology Physician provider writes 378 Medicare Part D claims per year.
What drugs does SHREEJA KADAKIA, MD prescribe most often?
Based on 2023 Medicare Part D data, SHREEJA KADAKIA, MD's most frequently prescribed drugs include Clopidogrel, Carbidopa-Levodopa, Duloxetine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SHREEJA KADAKIA, MD accept Medicare?
SHREEJA KADAKIA, MD appears in CMS Medicare data with 131 Part D claims and 38 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SHREEJA KADAKIA, MD's credentials?
SHREEJA KADAKIA, MD's NPI is 1902480874 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology